<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD07900000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P60484</UniProt_ID>
  <Seq_Length>403</Seq_Length>
  <Molecule_Weight>47166</Molecule_Weight>
  <KEGG_ID>hsa:5728</KEGG_ID>
  <Orthology_ID>K01110</Orthology_ID>
  <EBI_ID>EBI-696162</EBI_ID>
  <Function_Summary>Tumor suppressor. Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins. Also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate with order of substrate preference in vitro PtdIns(3,4,5)P3 </Function_Summary>
  <Catalytic_Mechanism>Phosphatidylinositol 3,4,5-trisphosphate + H(2)O = phosphatidylinositol 4,5-bisphosphate + phosphate.@@A phosphoprotein + H(2)O = a protein + phosphate.@@Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00782:DSPc@@PF10409:PTEN_C2</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Mutated in multiple advanced cancers 1</Alias>
      <Alias>Phosphatase and tensin homolog</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an anaphase-promoting complex. A ubiquitin ligase complex that degrades mitotic cyclins and anaphase inhibitory protein, thereby triggering sister chromatid separation and exit from mitosis.</Detail>
      <Keyword>Anaphase-promoting complex binding</Keyword>
      <Ontology_ID>GO:0010997</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: phosphatidylinositol-3,4-bisphosphate + H2O = phosphatidylinositol-4-phosphate + phosphate.</Detail>
      <Keyword>Phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity</Keyword>
      <Ontology_ID>GO:0051800</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.</Detail>
      <Keyword>Phosphoprotein phosphatase activity</Keyword>
      <Ontology_ID>GO:0004721</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a lipid.</Detail>
      <Keyword>Lipid binding</Keyword>
      <Ontology_ID>GO:0008289</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 3-phosphate + H2O = 1-phosphatidyl-1D-myo-inositol + phosphate.</Detail>
      <Keyword>Phosphatidylinositol-3-phosphatase activity</Keyword>
      <Ontology_ID>GO:0004438</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.</Detail>
      <Keyword>PDZ domain binding</Keyword>
      <Ontology_ID>GO:0030165</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: protein serine phosphate + H2O = protein serine + phosphate, and protein threonine phosphate + H2O = protein threonine + phosphate.</Detail>
      <Keyword>Protein serine/threonine phosphatase activity</Keyword>
      <Ontology_ID>GO:0004722</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with magnesium (Mg) ions.</Detail>
      <Keyword>Magnesium ion binding</Keyword>
      <Ontology_ID>GO:0000287</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.</Detail>
      <Keyword>Protein tyrosine phosphatase activity</Keyword>
      <Ontology_ID>GO:0004725</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: protein serine + H2O = protein serine + phosphate; protein threonine phosphate + H2O = protein threonine + phosphate; and protein tyrosine phosphate + H2O = protein tyrosine + phosphate.</Detail>
      <Keyword>Protein tyrosine/serine/threonine phosphatase activity</Keyword>
      <Ontology_ID>GO:0008138</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: phosphatidylinositol-3,4,5-trisphosphate + H2O = phosphatidylinositol-4,5-bisphosphate + phosphate.</Detail>
      <Keyword>Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity</Keyword>
      <Ontology_ID>GO:0016314</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: inositol-1,3,4,5-tetrakisphosphate + H2O = inositol-1,4,5-trisphosphate + phosphate.</Detail>
      <Keyword>Inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity</Keyword>
      <Ontology_ID>GO:0051717</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>132</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>123</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>57</Position>
      <Original>Leu</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>16</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>401</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>47</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>35</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>369</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>70</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Ile</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>107</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>19</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>347</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>15</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>42</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>71</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>290</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>341</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>123</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>34</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>348</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>345</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>10</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>343</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>119</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>20</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organ of an organism.</Detail>
      <Keyword>Negative regulation of organ growth</Keyword>
      <Ontology_ID>GO:0046621</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that initiates the ubiquitin ligase activity of the anaphase-promoting complex that regulates the mitotic metaphase/anaphase transition.</Detail>
      <Keyword>Activation of mitotic anaphase-promoting complex activity</Keyword>
      <Ontology_ID>GO:0007092</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that reduces cell size.</Detail>
      <Keyword>Negative regulation of cell size</Keyword>
      <Ontology_ID>GO:0045792</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The acquisition and processing of information and/or the storage and retrieval of this information over time.</Detail>
      <Keyword>Learning or memory</Keyword>
      <Ontology_ID>GO:0007611</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.</Detail>
      <Keyword>Positive regulation of transcription factor activity</Keyword>
      <Ontology_ID>GO:0051091</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process.</Detail>
      <Keyword>Positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process</Keyword>
      <Ontology_ID>GO:2000060</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.</Detail>
      <Keyword>Lipid metabolic process</Keyword>
      <Ontology_ID>GO:0006629</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.</Detail>
      <Keyword>Dendritic spine morphogenesis</Keyword>
      <Ontology_ID>GO:0060997</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.</Detail>
      <Keyword>Negative regulation of dendritic spine morphogenesis</Keyword>
      <Ontology_ID>GO:0061002</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to another neuron across a synapse.</Detail>
      <Keyword>Nerve-nerve synaptic transmission</Keyword>
      <Ontology_ID>GO:0007270</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of G1/S transition of mitotic cell cycle.</Detail>
      <Keyword>Negative regulation of G1/S transition of mitotic cell cycle</Keyword>
      <Ontology_ID>GO:2000134</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse.</Detail>
      <Keyword>Prepulse inhibition</Keyword>
      <Ontology_ID>GO:0060134</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the structure and material content of mature central nervous system myelin is kept in a functional state.</Detail>
      <Keyword>Central nervous system myelin maintenance</Keyword>
      <Ontology_ID>GO:0032286</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.</Detail>
      <Keyword>T cell receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0050852</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process that organizes a synapse so that it attains its fully functional state. Synaptic maturation plays a critical role in the establishment of effective synaptic connections in early development.</Detail>
      <Keyword>Synapse maturation</Keyword>
      <Ontology_ID>GO:0060074</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Behavior that occurs predominantly, or only, in individuals that are part of a group.</Detail>
      <Keyword>Social behavior</Keyword>
      <Ontology_ID>GO:0035176</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.</Detail>
      <Keyword>Canonical Wnt receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0060070</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of CDK activity contributing to the G1/S transition of the cell cycle.</Detail>
      <Keyword>Negative regulation of cyclin-dependent protein kinase activity involved in G1/S</Keyword>
      <Ontology_ID>GO:0031658</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The multiplication or reproduction of cells, resulting in the expansion of a cell population.</Detail>
      <Keyword>Cell proliferation</Keyword>
      <Ontology_ID>GO:0008283</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.</Detail>
      <Keyword>Nervous system development</Keyword>
      <Ontology_ID>GO:0007399</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Fibroblast growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0008543</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis</Keyword>
      <Ontology_ID>GO:0006917</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of removing a phosphate group from any mono- or polyphosphorylated inositol.</Detail>
      <Keyword>Inositol phosphate dephosphorylation</Keyword>
      <Ontology_ID>GO:0046855</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.</Detail>
      <Keyword>Negative regulation of focal adhesion assembly</Keyword>
      <Ontology_ID>GO:0051895</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.</Detail>
      <Keyword>Negative regulation of phosphatidylinositol 3-kinase cascade</Keyword>
      <Ontology_ID>GO:0014067</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of an epidermal growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Epidermal growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0007173</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Generation of a long process from a neuron whose cell body resides in the central nervous system. The process carries efferent (outgoing) action potentials from the cell body towards target cells.</Detail>
      <Keyword>Central nervous system neuron axonogenesis</Keyword>
      <Ontology_ID>GO:0021955</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that prevents the establishment or decreases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.</Detail>
      <Keyword>Negative regulation of excitatory postsynaptic membrane potential</Keyword>
      <Ontology_ID>GO:0090394</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The rhythm of the locomotor activity of an organism during its 24 hour activity cycle.</Detail>
      <Keyword>Locomotor rhythm</Keyword>
      <Ontology_ID>GO:0045475</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of cell proliferation.</Detail>
      <Keyword>Positive regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008284</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.</Detail>
      <Keyword>Negative regulation of protein phosphorylation</Keyword>
      <Ontology_ID>GO:0001933</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.</Detail>
      <Keyword>Negative regulation of cell migration</Keyword>
      <Ontology_ID>GO:0030336</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the generation of rhythmic, synchronous synaptic inputs in a neural circuit.</Detail>
      <Keyword>Rhythmic synaptic transmission</Keyword>
      <Ontology_ID>GO:0060024</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.</Detail>
      <Keyword>Protein stabilization</Keyword>
      <Ontology_ID>GO:0050821</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.</Detail>
      <Keyword>Phosphatidylinositol-mediated signaling</Keyword>
      <Ontology_ID>GO:0048015</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a multicellular organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).</Detail>
      <Keyword>Multicellular organismal response to stress</Keyword>
      <Ontology_ID>GO:0033555</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the protein kinase B signaling cascade, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.</Detail>
      <Keyword>Negative regulation of protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0051898</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the dentate gyrus over time, from its formation to the mature structure. The dentate gyrus is one of two interlocking gyri of the hippocampus. It contains granule cells, which project to the pyramidal cells and interneurons of the CA3 region of the ammon gyrus.</Detail>
      <Keyword>Dentate gyrus development</Keyword>
      <Ontology_ID>GO:0021542</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of axonogenesis.</Detail>
      <Keyword>Negative regulation of axonogenesis</Keyword>
      <Ontology_ID>GO:0050771</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of removing one or more phosphate groups from a phosphatidylinositol.</Detail>
      <Keyword>Phosphatidylinositol dephosphorylation</Keyword>
      <Ontology_ID>GO:0046856</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B, which occurs as a result of a single trigger reaction or compound.</Detail>
      <Keyword>Protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0043491</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which the anatomical structures of the forebrain are generated and organized. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).</Detail>
      <Keyword>Forebrain morphogenesis</Keyword>
      <Ontology_ID>GO:0048853</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of regulation of excitatory postsynaptic membrane potential.</Detail>
      <Keyword>Positive regulation of regulation of excitatory postsynaptic membrane potential</Keyword>
      <Ontology_ID>GO:2000463</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>6</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>366</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>385</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>401</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>380</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>383</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>370</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>382</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>336</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV</Protein_Seq>
    <DNA_Seq>CCTCCCCTCGCCCGGCGCGGTCCCGTCCGCCTCTCGCTCGCCTCCCGCCTCCCCTCGGTCTTCCGAGGCGCCCGGGCTCCCGGCGCGGCGGCGGAGGGGGCGGGCAGGCCGGCGGGCGGTGATGTGGCGGGACTCTTTATGCGCTGCGGCAGGATACGCGCTCGGCGCTGGGACGCGACTGCGCTCAGTTCTCTCCTCTCGGAAGCTGCAGCCATGATGGAAGTTTGAGAGTTGAGCCGCTGTGAGGCGAGGCCGGGCTCAGGCGAGGGAGATGAGAGACGGCGGCGGCCGCGGCCCGGAGCCCCTCTCAGCGCCTGTGAGCAGCCGCGGGGGCAGCGCCCTCGGGGAGCCGGCCGGCCTGCGGCGGCGGCAGCGGCGGCGTTTCTCGCCTCCTCTTCGTCTTTTCTAACCGTGCAGCCTCTTCCTCGGCTTCTCCTGAAAGGGAAGGTGGAAGCCGTGGGCTCGGGCGGGAGCCGGCTGAGGCGCGGCGGCGGCGGCGGCACCTCCCGCTCCTGGAGCGGGGGGGAGAAGCGGCGGCGGCGGCGGCCGCGGCGGCTGCAGCTCCAGGGAGGGGGTCTGAGTCGCCTGTCACCATTTCCAGGGCTGGGAACGCCGGAGAGTTGGTCTCTCCCCTTCTACTGCCTCCAACACGGCGGCGGCGGCGGCGGCACATCCAGGGACCCGGGCCGGTTTTAAACCTCCCGTCCGCCGCCGCCGCACCCCCCGTGGCCCGGGCTCCGGAGGCCGCCGGCGGAGGCAGCCGTTCGGAGGATTATTCGTCTTCTCCCCATTCCGCTGCCGCCGCTGCCAGGCCTCTGGCTGCTGAGGAGAAGCAGGCCCAGTCGCTGCAACCATCCAGCAGCCGCCGCAGCAGCCATTACCCGGCTGCGGTCCAGAGCCAAGCGGCGGCAGAGCGAGGGGCATCAGCTACCGCCAAGTCCAGAGCCATTTCCATCCTGCAGAAGAAGCCCCGCCACCAGCAGCTTCTGCCATCTCTCTCCTCCTTTTTCTTCAGCCACAGGCTCCCAGACATGACAGCCATCATCAAAGAGATCGTTAGCAGAAACAAAAGGAGATATCAAGAGGATGGATTCGACTTAGACTTGACCTATATTTATCCAAACATTATTGCTATGGGATTTCCTGCAGAAAGACTTGAAGGCGTATACAGGAACAATATTGATGATGTAGTAAGGTTTTTGGATTCAAAGCATAAAAACCATTACAAGATATACAATCTTTGTGCTGAAAGACATTATGACACCGCCAAATTTAATTGCAGAGTTGCACAATATCCTTTTGAAGACCATAACCCACCACAGCTAGAACTTATCAAACCCTTTTGTGAAGATCTTGACCAATGGCTAAGTGAAGATGACAATCATGTTGCAGCAATTCACTGTAAAGCTGGAAAGGGACGAACTGGTGTAATGATATGTGCATATTTATTACATCGGGGCAAATTTTTAAAGGCACAAGAGGCCCTAGATTTCTATGGGGAAGTAAGGACCAGAGACAAAAAGGGAGTAACTATTCCCAGTCAGAGGCGCTATGTGTATTATTATAGCTACCTGTTAAAGAATCATCTGGATTATAGACCAGTGGCACTGTTGTTTCACAAGATGATGTTTGAAACTATTCCAATGTTCAGTGGCGGAACTTGCAATCCTCAGTTTGTGGTCTGCCAGCTAAAGGTGAAGATATATTCCTCCAATTCAGGACCCACACGACGGGAAGACAAGTTCATGTACTTTGAGTTCCCTCAGCCGTTACCTGTGTGTGGTGATATCAAAGTAGAGTTCTTCCACAAACAGAACAAGATGCTAAAAAAGGACAAAATGTTTCACTTTTGGGTAAATACATTCTTCATACCAGGACCAGAGGAAACCTCAGAAAAAGTAGAAAATGGAAGTCTATGTGATCAAGAAATCGATAGCATTTGCAGTATAGAGCGTGCAGATAATGACAAGGAATATCTAGTACTTACTTTAACAAAAAATGATCTTGACAAAGCAAATAAAGACAAAGCCAACCGATACTTTTCTCCAAATTTTAAGGTGAAGCTGTACTTCACAAAAACAGTAGAGGAGCCGTCAAATCCAGAGGCTAGCAGTTCAACTTCTGTAACACCAGATGTTAGTGACAATGAACCTGATCATTATAGATATTCTGACACCACTGACTCTGATCCAGAGAATGAACCTTTTGATGAAGATCAGCATACACAAATTACAAAAGTCTGAATTTTTTTTTATCAAGAGGGATAAAACACCATGAAAATAAACTTGAATAAACTGAAAATGGACCTTTTTTTTTTTAATGGCAATAGGACATTGTGTCAGATTACCAGTTATAGGAACAATTCTCTTTTCCTGACCAATCTTGTTTTACCCTATACATCCACAGGGTTTTGACACTTGTTGTCCAGTTGAAAAAAGGTTGTGTAGCTGTGTCATGTATATACCTTTTTGTGTCAAAAGGACATTTAAAATTCAATTAGGATTAATAAAGATGGCACTTTCCCGTTTTATTCCAGTTTTATAAAAAGTGGAGACAGACTGATGTGTATACGTAGGAATTTTTTCCTTTTGTGTTCTGTCACCAACTGAAGTGGCTAAAGAGCTTTGTGATATACTGGTTCACATCCTACCCCTTTGCACTTGTGGCAACAGATAAGTTTGCAGTTGGCTAAGAGAGGTTTCCGAAGGGTTTTGCTACATTCTAATGCATGTATTCGGGTTAGGGGAATGGAGGGAATGCTCAGAAAGGAAATAATTTTATGCTGGACTCTGGACCATATACCATCTCCAGCTATTTACACACACCTTTCTTTAGCATGCTACAGTTATTAATCTGGACATTCGAGGAATTGGCCGCTGTCACTGCTTGTTGTTTGCGCATTTTTTTTTAAAGCATATTGGTGCTAGAAAAGGCAGCTAAAGGAAGTGAATCTGTATTGGGGTACAGGAATGAACCTTCTGCAACATCTTAAGATCCACAAATGAAGGGATATAAAAATAATGTCATAGGTAAGAAACACAGCAACAATGACTTAACCATATAAATGTGGAGGCTATCAACAAAGAATGGGCTTGAAACATTATAAAAATTGACAATGATTTATTAAATATGTTTTCTCAATTGTAACGACTTCTCCATCTCCTGTGTAATCAAGGCCAGTGCTAAAATTCAGATGCTGTTAGTACCTACATCAGTCAACAACTTACACTTATTTTACTAGTTTTCAATCATAATACCTGCTGTGGATGCTTCATGTGCTGCCTGCAAGCTTCTTTTTTCTCATTAAATATAAAATATTTTGTAATGCTGCACAGAAATTTTCAATTTGAGATTCTACAGTAAGCGTTTTTTTTCTTTGAAGATTTATGATGCACTTATTCAATAGCTGTCAGCCGTTCCACCCTTTTGACCTTACACATTCTATTACAATGAATTTTGCAGTTTTGCACATTTTTTAAATGTCATTAACTGTTAGGGAATTTTACTTGAATACTGAATACATATAATGTTTATATTAAAAAGGACATTTGTGTTAAAAAGGAAATTAGAGTTGCAGTAAACTTTCAATGCTGCACACAAAAAAAAGACATTTGATTTTTCAGTAGAAATTGTCCTACATGTGCTTTATTGATTTGCTATTGAAAGAATAGGGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTAAATGTGCAGTGTTGAATCATTTCTTCATAGTGCTCCCCCGAGTTGGGACTAGGGCTTCAATTTCACTTCTTAAAAAAAATCATCATATATTTGATATGCCCAGACTGCATACGATTTTAAGCGGAGTACAACTACTATTGTAAAGCTAATGTGAAGATATTATTAAAAAGGTTTTTTTTTCCAGAAATTTGGTGTCTTCAAATTATACCTTCACCTTGACATTTGAATATCCAGCCATTTTGTTTCTTAATGGTATAAAATTCCATTTTCAATAACTTATTGGTGCTGAAATTGTTCACTAGCTGTGGTCTGACCTAGTTAATTTACAAATACAGATTGAATAGGACCTACTAGAGCAGCATTTATAGAGTTTGATGGCAAATAGATTAGGCAGAACTTCATCTAAAATATTCTTAGTAAATAATGTTGACACGTTTTCCATACCTTGTCAGTTTCATTCAACAATTTTTAAATTTTTAACAAAGCTCTTAGGATTTACACATTTATATTTAAACATTGATATATAGAGTATTGATTGATTGCTCATAAGTTAAATTGGTAAAGTTAGAGACAACTATTCTAACACCTCACCATTGAAATTTATATGCCACCTTGTCTTTCATAAAAGCTGAAAATTGTTACCTAAAATGAAAATCAACTTCATGTTTTGAAGATAGTTATAAATATTGTTCTTTGTTACAATTTCGGGCACCGCATATTAAAACGTAACTTTATTGTTCCAATATGTAACATGGAGGGCCAGGTCATAAATAATGACATTATAATGGGCTTTTGCACTGTTATTATTTTTCCTTTGGAATGTGAAGGTCTGAATGAGGGTTTTGATTTTGAATGTTTCAATGTTTTTGAGAAGCCTTGCTTACATTTTATGGTGTAGTCATTGGAAATGGAAAAATGGCATTATATATATTATATATATAAATATATATTATACATACTCTCCTTACTTTATTTCAGTTACCATCCCCATAGAATTTGACAAGAATTGCTATGACTGAAAGGTTTTCGAGTCCTAATTAAAACTTTATTTATGGCAGTATTCATAATTAGCCTGAAATGCATTCTGTAGGTAATCTCTGAGTTTCTGGAATATTTTCTTAGACTTTTTGGATGTGCAGCAGCTTACATGTCTGAAGTTACTTGAAGGCATCACTTTTAAGAAAGCTTACAGTTGGGCCCTGTACCATCCCAAGTCCTTTGTAGCTCCTCTTGAACATGTTTGCCATACTTTTAAAAGGGTAGTTGAATAAATAGCATCACCATTCTTTGCTGTGGCACAGGTTATAAACTTAAGTGGAGTTTACCGGCAGCATCAAATGTTTCAGCTTTAAAAAATAAAAGTAGGGTACAAGTTTAATGTTTAGTTCTAGAAATTTTGTGCAATATGTTCATAACGATGGCTGTGGTTGCCACAAAGTGCCTCGTTTACCTTTAAATACTGTTAATGTGTCATGCATGCAGATGGAAGGGGTGGAACTGTGCACTAAAGTGGGGGCTTTAACTGTAGTATTTGGCAGAGTTGCCTTCTACCTGCCAGTTCAAAAGTTCAACCTGTTTTCATATAGAATATATATACTAAAAAATTTCAGTCTGTTAAACAGCCTTACTCTGATTCAGCCTCTTCAGATACTCTTGTGCTGTGCAGCAGTGGCTCTGTGTGTAAATGCTATGCACTGAGGATACACAAAAATACCAATATGATGTGTACAGGATAATGCCTCATCCCAATCAGATGTCCATTTGTTATTGTGTTTGTTAACAACCCTTTATCTCTTAGTGTTATAAACTCCACTTAAAACTGATTAAAGTCTCATTCTTGTCAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell projection</CellLocal>
      <Ontology_ID>GO:0042995</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Synaptosome</CellLocal>
      <Ontology_ID>GO:0019717</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>PML body</CellLocal>
      <Ontology_ID>GO:0016605</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Schmidt-Lanterman incisure</CellLocal>
      <Ontology_ID>GO:0043220</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Internal side of plasma membrane</CellLocal>
      <Ontology_ID>GO:0009898</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PTEN</Gene_Name>
    <Gene_Alias>MMAC1; TEP1</Gene_Alias>
    <Gene_ID>5728</Gene_ID>
    <Genbank_ACCN>NM_000314</Genbank_ACCN>
    <Protein_ACCN>NP_000305</Protein_ACCN>
    <HGNC_ID>9588</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5728</Gene_URL>
    <UCSC_ID>uc001kfb.3</UCSC_ID>
    <EMBL_ID>ENSG00000171862</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q60592</Uniprot_ID>
      <Gene_Name>Mast2</Gene_Name>
      <EBI_ID>EBI-493888</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-493888</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P46934</Uniprot_ID>
      <Gene_Name>NEDD4</Gene_Name>
      <EBI_ID>EBI-726944</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-726944</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P30260</Uniprot_ID>
      <Gene_Name>CDC27</Gene_Name>
      <EBI_ID>EBI-994813</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-994813</PPI_EBI_URL>
      <Experiment_Number>7</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P62136</Uniprot_ID>
      <Gene_Name>PPP1CA</Gene_Name>
      <EBI_ID>EBI-357253</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-357253</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O60307</Uniprot_ID>
      <Gene_Name>MAST3</Gene_Name>
      <EBI_ID>EBI-311420</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-311420</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O88382</Uniprot_ID>
      <Gene_Name>Magi2</Gene_Name>
      <EBI_ID>EBI-696179</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-696179</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9R1L5</Uniprot_ID>
      <Gene_Name>Mast1</Gene_Name>
      <EBI_ID>EBI-491771</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-491771</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P42685</Uniprot_ID>
      <Gene_Name>FRK</Gene_Name>
      <EBI_ID>EBI-1383583</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-1383583</PPI_EBI_URL>
      <Experiment_Number>7</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q62696</Uniprot_ID>
      <Gene_Name>Dlg1</Gene_Name>
      <EBI_ID>EBI-389325</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-389325</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9JK71</Uniprot_ID>
      <Gene_Name>Magi3</Gene_Name>
      <EBI_ID>EBI-696226</EBI_ID>
      <PPI_EBI_URL>EBI-696162,EBI-696226</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Oligodendroglioma</Disease_Name>
      <Disease_Detail>Oligodendroglioma</Disease_Detail>
      <Disease_DB>OLG002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oligodendroglioma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometrial Carcinoma, Somatic</Disease_Name>
      <Disease_Detail>Endometrial Cancer</Disease_Detail>
      <Disease_DB>END058</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometrial_carcinoma_somatic?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Melanoma, Malignant, Somatic</Disease_Name>
      <Disease_Detail>Melanoma</Disease_Detail>
      <Disease_DB>MLN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/melanoma_malignant_somatic?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Turcot Syndrome</Disease_Name>
      <Disease_Detail>Turcot Syndrome</Disease_Detail>
      <Disease_DB>TRC032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/turcot_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epidermal Nevus</Disease_Name>
      <Disease_Detail>Epidermal Nevus</Disease_Detail>
      <Disease_DB>EPD037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epidermal_nevus?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Anaplastic Ependymoma</Disease_Name>
      <Disease_Detail>Anaplastic Ependymoma</Disease_Detail>
      <Disease_DB>ANP006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/anaplastic_ependymoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer, Hereditary, 5</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS079</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer_hereditary_5?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Squamous Cell Carcinoma of the Head and Neck</Disease_Name>
      <Disease_Detail>Squamous Cell Carcinoma, Head and Neck</Disease_Detail>
      <Disease_DB>SQM007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/squamous_cell_carcinoma_of_the_head_and_neck?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gliomatosis Cerebri</Disease_Name>
      <Disease_Detail>Gliomatosis Cerebri</Disease_Detail>
      <Disease_DB>GLM004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gliomatosis_cerebri?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Laryngeal Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Laryngeal Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>LRY018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/laryngeal_squamous_cell_carcinoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemimegalencephaly</Disease_Name>
      <Disease_Detail>Hemimegalencephaly</Disease_Detail>
      <Disease_DB>HMM003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemimegalencephaly?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Keloid Formation</Disease_Name>
      <Disease_Detail>Keloid Formation</Disease_Detail>
      <Disease_DB>KLD003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/keloid_formation?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Proteus-Like Syndrome</Disease_Name>
      <Disease_Detail>Proteus Syndrome</Disease_Detail>
      <Disease_DB>PRT063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/proteus_like_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bannayan-Riley-Ruvalcaba Syndrome</Disease_Name>
      <Disease_Detail>Bannayan-Riley-Ruvalcaba Syndrome</Disease_Detail>
      <Disease_DB>BNN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bannayan_riley_ruvalcaba_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Histiocytic Sarcoma</Disease_Name>
      <Disease_Detail>Histiocytic Sarcoma</Disease_Detail>
      <Disease_DB>HST016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/histiocytic_sarcoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mixed Germ Cell Tumor</Disease_Name>
      <Disease_Detail>Mixed Germ Cell Tumor</Disease_Detail>
      <Disease_DB>MXD032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mixed_germ_cell_tumor?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gliosarcoma</Disease_Name>
      <Disease_Detail>Gliosarcoma</Disease_Detail>
      <Disease_DB>GLS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gliosarcoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer 4</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS105</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer_4?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer 3</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS104</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer_3?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tracheoesophageal Fistula</Disease_Name>
      <Disease_Detail>Tracheoesophageal Fistula</Disease_Detail>
      <Disease_DB>TRC040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tracheoesophageal_fistula?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometrial Cancer, Familial</Disease_Name>
      <Disease_Detail>Endometrial Cancer</Disease_Detail>
      <Disease_DB>END056</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometrial_cancer_familial?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Cancer</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_cancer?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Proteus Syndrome</Disease_Name>
      <Disease_Detail>Proteus Syndrome</Disease_Detail>
      <Disease_DB>PRT008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/proteus_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vacterl Association with Hydrocephalus</Disease_Name>
      <Disease_Detail>Vacterl Association with Hydrocephalus</Disease_Detail>
      <Disease_DB>VCT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vacterl_association_with_hydrocephalus?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Carcinoma, Follicular, Somatic</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY059</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_carcinoma_follicular_somatic?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lipomatosis</Disease_Name>
      <Disease_Detail>Lipomatosis</Disease_Detail>
      <Disease_DB>LPM005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lipomatosis?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vacterl Association</Disease_Name>
      <Disease_Detail>Vacterl Association</Disease_Detail>
      <Disease_DB>VCT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vacterl_association?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Malignant Lymphoma</Disease_Name>
      <Disease_Detail>Primary Malignant Lymphoma</Disease_Detail>
      <Disease_DB>PRM046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_malignant_lymphoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arteriovenous Malformation</Disease_Name>
      <Disease_Detail>Arteriovenous Malformation</Disease_Detail>
      <Disease_DB>ART005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arteriovenous_malformation?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Polyposis Syndrome</Disease_Name>
      <Disease_Detail>Juvenile Polyposis Syndrome</Disease_Detail>
      <Disease_DB>JVN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_polyposis_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Astrocytoma</Disease_Name>
      <Disease_Detail>Astrocytoma</Disease_Detail>
      <Disease_DB>AST007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/astrocytoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atypical Mole Syndrome</Disease_Name>
      <Disease_Detail>Atypical Mole Syndrome</Disease_Detail>
      <Disease_DB>ATY019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atypical_mole_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ruvalcaba Syndrome</Disease_Name>
      <Disease_Detail>Ruvalcaba Syndrome</Disease_Detail>
      <Disease_DB>RVL002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ruvalcaba_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Giant Cell Glioblastoma</Disease_Name>
      <Disease_Detail>Giant Cell Glioblastoma</Disease_Detail>
      <Disease_DB>GNT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/giant_cell_glioblastoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Li-Fraumeni Syndrome</Disease_Name>
      <Disease_Detail>Li-Fraumeni Syndrome</Disease_Detail>
      <Disease_DB>LFR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/li_fraumeni_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemihypertrophy</Disease_Name>
      <Disease_Detail>Hemihypertrophy</Disease_Detail>
      <Disease_DB>HMH002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemihypertrophy?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Squamous Cell Carcinoma, Head and Neck, Somatic</Disease_Name>
      <Disease_Detail>Squamous Cell Carcinoma, Head and Neck</Disease_Detail>
      <Disease_DB>SQM009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/squamous_cell_carcinoma_head_and_neck_somatic?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gangliocytoma</Disease_Name>
      <Disease_Detail>Gangliocytoma</Disease_Detail>
      <Disease_DB>GNG005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gangliocytoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Cancer</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_cancer?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast-Ovarian Cancer, Familial, 1</Disease_Name>
      <Disease_Detail>Breast-Ovarian Cancer</Disease_Detail>
      <Disease_DB>BRS071</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_ovarian_cancer_familial_1?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningioma</Disease_Name>
      <Disease_Detail>Meningioma</Disease_Detail>
      <Disease_DB>MNN012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningioma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Proteus Syndrome, Somatic</Disease_Name>
      <Disease_Detail>Proteus Syndrome</Disease_Detail>
      <Disease_DB>PRT093</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/proteus_syndrome_somatic?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glioma Susceptibility 2</Disease_Name>
      <Disease_Detail>Glioma Susceptibility</Disease_Detail>
      <Disease_DB>GLM025</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glioma_susceptibility_2?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Segmental Outgrowth - Lipomatosis - Arteriovenous Malformation - Epidermal Nevus</Disease_Name>
      <Disease_Detail>Segmental Outgrowth - Lipomatosis - Arteriovenous Malformation - Epidermal Nevus</Disease_Detail>
      <Disease_DB>SGM007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/segmental_outgrowth_lipomatosis_arteriovenous_malformation_epidermal_nevus?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenofibroma</Disease_Name>
      <Disease_Detail>Adenofibroma</Disease_Detail>
      <Disease_DB>ADN017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenofibroma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cowden Disease</Disease_Name>
      <Disease_Detail>Cowden Disease</Disease_Detail>
      <Disease_DB>CWD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cowden_disease?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endometrial Carcinoma</Disease_Name>
      <Disease_Detail>Endometrial Cancer</Disease_Detail>
      <Disease_DB>END042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endometrial_carcinoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gemistocytic Astrocytoma</Disease_Name>
      <Disease_Detail>Gemistocytic Astrocytoma</Disease_Detail>
      <Disease_DB>GMS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gemistocytic_astrocytoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pten Hamartoma Tumor Syndrome</Disease_Name>
      <Disease_Detail>Pten Hamartoma Tumor Syndrome</Disease_Detail>
      <Disease_DB>PTN006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pten_hamartoma_tumor_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Birt-Hogg-Dube Syndrome</Disease_Name>
      <Disease_Detail>Birt-Hogg-Dube Syndrome</Disease_Detail>
      <Disease_DB>BRT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/birt_hogg_dube_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer, Progression of</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS085</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer_progression_of?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cowden Syndrome 1</Disease_Name>
      <Disease_Detail>Cowden Syndrome</Disease_Detail>
      <Disease_DB>CWD006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cowden_syndrome_1?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glioblastoma</Disease_Name>
      <Disease_Detail>Glioblastoma</Disease_Detail>
      <Disease_DB>GLB002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glioblastoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ependymoma</Disease_Name>
      <Disease_Detail>Ependymoma</Disease_Detail>
      <Disease_DB>EPN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ependymoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Macrocephaly/autism Syndrome</Disease_Name>
      <Disease_Detail>Macrodactyly</Disease_Detail>
      <Disease_DB>MCR096</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/macrocephaly_autism_syndrome?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vater Association with Macrocephaly and Ventriculomegaly</Disease_Name>
      <Disease_Detail>Vater Association with Macrocephaly and Ventriculomegaly</Disease_Detail>
      <Disease_DB>VTR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vater_association_with_macrocephaly_and_ventriculomegaly?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Polyposis of Infancy</Disease_Name>
      <Disease_Detail>Juvenile Polyposis of Infancy</Disease_Detail>
      <Disease_DB>JVN034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_polyposis_of_infancy?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer, Somatic</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS065</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer_somatic?search=PTEN#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multilocular Cystic Renal Cell Carcinoma</Disease_Name>
      <Disease_Detail>Multilocular Cystic Renal Cell Carcinoma</Disease_Detail>
      <Disease_DB>MLT107</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multilocular_cystic_renal_cell_carcinoma?search=PTEN#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal Structure of the PTEN Tumor Suppressor</PDB_Title>
      <PDB_ID>1D5R</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D5R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.</PubMed_Title>
      <Author>Lee, J.O., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(1999)99:323-334</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10555148?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of MAST2-PDZ complexed with the C-terminus of PTEN</PDB_Title>
      <PDB_ID>2KYL</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2KYL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of MAST2-PDZ complexed with the C-terminus of PTEN</PubMed_Title>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00562</Pathway_ID>
      <Pathway_Title>Inositol phosphate metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05215</Pathway_ID>
      <Pathway_Title>Prostate cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05230</Pathway_ID>
      <Pathway_Title>Central carbon metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04070</Pathway_ID>
      <Pathway_Title>Phosphatidylinositol signaling system</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04151</Pathway_ID>
      <Pathway_Title>PI3K-Akt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04070</Pathway_ID>
      <Pathway_Title>Phosphatidylinositol signaling system</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05222</Pathway_ID>
      <Pathway_Title>Small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04115</Pathway_ID>
      <Pathway_Title>p53 signaling pathway</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04151</Pathway_ID>
      <Pathway_Title>PI3K-Akt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04530</Pathway_ID>
      <Pathway_Title>Tight junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05213</Pathway_ID>
      <Pathway_Title>Endometrial cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05161</Pathway_ID>
      <Pathway_Title>Hepatitis B</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04068</Pathway_ID>
      <Pathway_Title>FoxO signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04150</Pathway_ID>
      <Pathway_Title>mTOR signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04510</Pathway_ID>
      <Pathway_Title>Focal adhesion</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04070</Pathway_ID>
      <Pathway_Title>Phosphatidylinositol signaling system</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.gg.b.b.e.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1d5r</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Ligand-induced conformational change</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.1.3.16</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/3/16.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID> 3.1.3.48</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC 3/1/3/48.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID> 3.1.3.67</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC 3/1/3/67.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD07900001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>